Comparison of Different Walk and Performance Test in Detecting Silent Hypoxia
NCT ID: NCT05709262
Last Updated: 2023-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2021-12-19
2022-12-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Clinical Effects of Coenzyme Q10 Levels in COVID-19 Patients in Intensive Care Unit
NCT05058716
Risk Identification of Long-term Complications
NCT06235866
Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients
NCT01068990
Fluid Responsiveness Predicted by PtcO2 in Critically Ill Patients
NCT02083757
Pneumonia in the Intensive Care Unit (ICU) Setting
NCT02685930
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with a SaO2 value \> 93 in room air
* Patients who do not have dyspnea symptoms in room air during rest
* Patients whose breathing frequence \< 21 at rest
* Patients who can walk independently and get up from their seat
* Patients who did not receive any rehabilitation
* Patients who can cooperate and who are fully oriented
* Patients who volunteered to participate in the study
Exclusion Criteria
* Exacerbation, severe respiratory failure (resting partial pressure of oxygen in standard ambient conditions of less than 55 mmHg), and inability or unwillingness to understand or comply with the study protocol.
* Unable to walk unaided
* Patients diagnosed with vertigo, Meniere, etc. balance disorder and dizziness
* Patients diagnosed with orthostatic hypotension
* Patients diagnosed with neurologic disease such as: stroke, ms-like neuromotor pathology
* pregnant women and those diagnosed with epilepsy
* Patients with BMI \> 35
* Patients with problems in cooperation
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kutahya Health Sciences University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ismail Saracoglu
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ismail Saracoglu
Role: PRINCIPAL_INVESTIGATOR
Kutahya Health Sciences University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kutahya Health Sciences University Evliya Celebi Hospital Physical Therapy and Rehabilitation Department
Kütahya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KSBUSilentHypoxi
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.